Market-ready Advicenne seeks partners and EUR 40 million VC funds

February 28, 2017 Christoph Graener

With a focus on pediatric neurology and nephrology, Dr. Luc-André Granier, founder, CEO and medical director of the 10-year old Nimes, France-based Advicenne Pharma SA, explains to Mike Ward, Informa Pharma Intelligence’s insights global director of content, how he is looking to raise EUR 40 million from VCs in the next two years, while looking for partners to complete development of and commercialize his market-ready and late Phase II assets.

Interviewer: Mike Ward – Global Director of Content, Informa Pharma Insights
Interviewee: Luc-André Granier – Founder, CEO and Medical Director, Advicenne Pharma SA

Previous Article
BioInvent discusses recent Pfizer immunotherapy alliance

Three years after setting out to turn BioInvent around, company president and CEO Michael Oredsson explains...

Next Article
Seventure expects uptick in microbiome-focused VC investments

Having closed a EUR 160 million venture fund focusing exclusively on microbiome-related fields, Seventure P...